Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study

References

• Baba, S., Furuta, T., Fujioka, M., & Goromaru, T. (1983). Studies on drug metabolism by use of isotopes XXVII: Urinary metabolites of rutin in rats and the role of intestinal microflora in the metabolism of rutin. Journal of Pharmaceutical Sciences, 72(10), 1155–1158. doi:10.1002/jps.2600721011
   PubMed Web of Science ®Google Scholar
• Bang, S. H., Hyun, Y. J., Shim, J., Hong, S. W., & Kim, D. H. (2015). Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing α-L-rhamnosidase from Bifidobacterium dentium. Journal of Microbiology and Biotechnology, 25(1), 18–25. doi:10.4014/jmb.1404.04060
   PubMed Web of Science ®Google Scholar
• Baum, C. E., Ockers, S. B., English, B. C., Price, D. K., Sartor, O., & Figg, W. D. (2010). Androgen receptor sequence and variations in several common prostate cancer cell lines. Cancer Biology & Therapy, 9(5), 383–388. doi:10.4161/cbt.9.5.10891
   PubMed Web of Science ®Google Scholar
• Culig, Z. (2014). Targeting the androgen receptor in prostate cancer. Expert Opinion on Pharmacotherapy, 15(10), 1427–1437. doi:10.1517/14656566.2014.915313
   PubMed Web of Science ®Google Scholar
• Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. In: J. Hempel, C. Williams, & C Hong (Eds.), Chemical biology (pp. 243–250). New York, NY: Humana Press.
   Google Scholar
• Dehm, S. M., & Tindall, D. J. (2005). Regulation of androgen receptor signaling in prostate cancer. Expert Review of Anticancer Therapy, 5(1), 63–74. doi:10.1586/14737140.5.1.63
   PubMed Web of Science ®Google Scholar
• de Sousa, L. R. F., Ramalho, S. D., Burger, M. C. D M., Nebo, L., Fernandes, J. B., da Silva, M. F. D G. F., … Vieira, P. C. (2014). Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems. Journal of Natural Products, 77(2), 392–396. doi:10.1021/np400717m
   PubMed Web of Science ®Google Scholar
• Divakar, S., Saravanan, K., Karthikeyan, P., Elancheran, R., Kabilan, S., Balasubramanian, K. K., … Ramanathan, M. (2017). Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway. Chemico-Biological Interactions, 275, 22–34. doi:10.1016/j.cbi.2017.07.023
   PubMed Web of Science ®Google Scholar
• Dixon, R. A. (2004). Phytoestrogens. Annual Review of Plant Biology, 55 (1), 225–261. doi:10.1146/annurev.arplant.55.031903.141729
   PubMed Web of Science ®Google Scholar
• Fang, H., Tong, W., Branham, W. S., Moland, C. L., Dial, S. L., Hong, H., … Sheehan, D. M. (2003). Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chemical Research in Toxicology, 16(10), 1338–1358. doi:10.1021/tx030011g
   PubMed Web of Science ®Google Scholar
• Fizazi, K., Albiges, L., Loriot, Y., & Massard, C. (2015). ODM-201: A new-generation androgen receptor inhibitor in castration-resistant prostate cancer. Expert Review of Anticancer Therapy, 15(9), 1007–1017. doi:10.1586/14737140.2015.1081566
   PubMed Web of Science ®Google Scholar
• Gao, W., Bohl, C. E., & Dalton, J. T. (2005). Chemistry and structural biology of androgen receptor. Chemical Reviews, 105(9), 3352–3370. doi:10.1021/cr020456u
   PubMed Web of Science ®Google Scholar
• Guo, C., Pairish, M., Linton, A., Kephart, S., Ornelas, M., Nagata, A., … Fanjul, A. N. (2012). Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters, 22(7), 2572–2578. doi:10.1016/j.bmcl.2012.01.116
   PubMed Web of Science ®Google Scholar
• He, B., Kemppainen, J. A., & Wilson, E. M. (2000). FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. Journal of Biological Chemistry, 275(30), 22986–22994. doi:10.1074/jbc.M002807200
   PubMed Web of Science ®Google Scholar
• Hur, E., Pfaff, S. J., Payne, E. S., Grøn, H., Buehrer, B. M., & Fletterick, R. J. (2004). Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biology, 2(9), e274. doi:10.1371/journal.pbio.0020274
   PubMed Web of Science ®Google Scholar
• Inoue, T., Kobayashi, T., Terada, N., Shimizu, Y., Kamoto, T., Ogawa, O., & Nakamura, E. (2007). Roles of androgen-dependent and-independent activation of signal transduction pathways for cell proliferation of prostate cancer cells. Expert Review of Endocrinology & Metabolism, 2(5), 689–704. doi:10.1586/17446651.2.5.689
   PubMedGoogle Scholar
• Jariwala, U., Prescott, J., Jia, L., Barski, A., Pregizer, S., Cogan, J. P., … Frenkel, B. (2007). Identification of novel androgen receptor target genes in prostate cancer. Molecular Cancer, 6(1), 39. doi:10.1186/1476-4598-6-39
   PubMed Web of Science ®Google Scholar
• Jeong, E. J., Cho, J. H., Sung, S. H., Kim, S. Y., & Kim, Y. C. (2011). Inhibition of nitric oxide production in lipopolysaccharide-stimulated RAW264. 7 macrophage cells by lignans isolated from Euonymus alatus leaves and twigs. Bioorganic & Medicinal Chemistry Letters, 21(8), 2283–2286. doi:10.1016/j.bmcl.2011.02.102
   PubMed Web of Science ®Google Scholar
• Kim, D. H., Han, S. B., Bae, E. A., & Han, M. J. (1996). Intestinal bacterial metabolism of rutin and its relation to mutagenesis. Archives of Pharmacal Research, 19(1), 41–45. doi:10.1007/BF02976818
   Web of Science ®Google Scholar
• Kim, D. H., Lee, K. T., Bae, E. A., Han, M. J., & Park, H. J. (1999). Metabolism of liriodendrin and syringin by human intestinal bacteria and their relation to in vitro cytotoxicity. Archives of Pharmacal Research, 22(1), 30–34. doi:10.1007/BF02976432
   PubMed Web of Science ®Google Scholar
• Kim, H. M., Kim, S. J., Kim, H. Y., Ryu, B., Kwak, H., Hur, J., … Jang, D. S. (2015). Constituents of the stem barks of Ailanthus altissima and their potential to inhibit LPS-induced nitric oxide production. Bioorganic & Medicinal Chemistry Letters, 25(5), 1017–1020. doi:10.1016/j.bmcl.2015.01.034
   PubMed Web of Science ®Google Scholar
• Korpal, M., Korn, J. M., Gao, X., Rakiec, D. P., Ruddy, D. A., Doshi, S., … Zhu, P. (2013). An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discovery, 3(9), 1030–1043. doi:10.1158/2159-8290.CD-13-0142
   PubMed Web of Science ®Google Scholar
• Li, J., & Al-Azzawi, F. (2009). Mechanism of androgen receptor action. Maturitas, 63(2), 142–148. doi:10.1016/j.maturitas.2009.03.008
   PubMed Web of Science ®Google Scholar
• Liao, R. S., Ma, S., Miao, L., Li, R., Yin, Y., & Raj, G. V. (2013). Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation. Translational Andrology and Urology, 2(3), 187–196. doi:10.3978/j.issn.2223-4683.2013.09.07
   PubMedGoogle Scholar
• Liu, H., Wang, L., Tian, J., Li, J., & Liu, H. (2017). Molecular dynamics studies on the enzalutamide resistance mechanisms induced by androgen receptor mutations. Journal of Cellular Biochemistry, 118(9), 2792–2801. doi:10.1002/jcb.25928
   PubMed Web of Science ®Google Scholar
• Liu, H., Han, R., Li, J., Liu, H., & Zheng, L. (2016). Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation. Journal of Computer-Aided Molecular Design, 30(12), 1189–1200. doi:10.1007/s10822-016-9992-2
   PubMed Web of Science ®Google Scholar
• Luecha, P., Umehara, K., Miyase, T., & Noguchi, H. (2009). Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata. Journal of Natural Products, 72(11), 1954–1959. doi:10.1021/np9006298
   PubMed Web of Science ®Google Scholar
• Mahmoud, A. M., Zhu, T., Parray, A., Siddique, H. R., Yang, W., Saleem, M., & Bosland, M. C. (2013). Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor. PLoS One, 8(10), e78479. doi:10.1371/journal.pone.0078479
   PubMed Web of Science ®Google Scholar
• Massie, C. E., Lynch, A., Ramos-Montoya, A., Boren, J., Stark, R., Fazli, L., … Mills, I. G. (2011). The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. The EMBO Journal, 30(13), 2719–2733. doi:10.1038/emboj.2011.158
   PubMed Web of Science ®Google Scholar
• Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., … Carrondo, M. A. (2000). Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implications for pathogenic gene mutations. Journal of Biological Chemistry, 275(34), 26164–26171. doi:10.1074/jbc.M004571200
   PubMed Web of Science ®Google Scholar
• McCrea, E., Sissung, T. M., Price, D. K., Chau, C. H., & Figg, W. D. (2016). Androgen receptor variation affects prostate cancer progression and drug resistance. Pharmacological Research, 114, 152–162. doi:10.1016/j.phrs.2016.10.001
   PubMed Web of Science ®Google Scholar
• Panwar, U., & Singh, S. K. (2018). Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75). Journal of Biomolecular Structure and Dynamics, 36(12), 3199–3217. doi:10.1080/07391102.2017.1384400
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera—A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. doi:10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Ryan, C. J., & Cheng, M. L. (2013). Abiraterone acetate for the treatment of prostate cancer. Expert Opinion on Pharmacotherapy, 14(1), 91–96. doi:10.1517/14656566.2013.745852
   PubMed Web of Science ®Google Scholar
• Saad, F., & Hotte, S. J. (2010). Guidelines for the management of castrate-resistant prostate cancer. Canadian Urological Association Journal, 4(6), 380–384. doi:10.5489/cuaj.949
   PubMed Web of Science ®Google Scholar
• Saarinen, N. M., Tuominen, J., Pylkkänen, L., & Santti, R. (2010). Assessment of information to substantiate a health claim on the prevention of prostate cancer by lignans. Nutrients, 2(2), 99–115. doi:10.3390/nu2020099
   PubMed Web of Science ®Google Scholar
• Saraon, P., Drabovich, A. P., Jarvi, K. A., & Diamandis, E. P. (2014). Mechanisms of androgen-independent prostate cancer. EJIFCC, 25(1), 42–54. doi:10.1002/pros.22747
   PubMedGoogle Scholar
• Schalken, J. A., Bergh, A., Bono, A., Foster, C., Gospadarowicz, M., Isaacs, W. B., … Wiklund, P. (2005). Molecular prostate cancer pathology: Current issues and achievements. Scandinavian Journal of Urology and Nephrology, 39(sup216), 82–93. doi:10.1080/03008880510030950
   PubMed Web of Science ®Google Scholar
• Selvaraj, D., Hariharan, S., & Muthiah, R. (2017). Identification of pharmacophore for wild and T877A mutant androgen receptor antagonist: Challenges in designing 3D-QSAR for mutant protein. International Journal of Quantitative Structure-Property Relationships, 2(2), 47–61. doi:10.4018/IJQSPR.2017070105
   Google Scholar
• Sirotkin, A. V., & Harrath, A. H. (2014). Phytoestrogens and their effects. European Journal of Pharmacology, 741, 230–236. doi:10.1016/j.ejphar.2014.07.057
   PubMed Web of Science ®Google Scholar
• Sivoňová, M. K., Kaplán, P., Tatarková, Z., Lichardusová, L., Dušenka, R., & Jurečeková, J. (2019). Androgen receptor and soy isoflavones in prostate cancer. Molecular and Clinical Oncology, 10(2), 191–204. doi:10.3892/mco.2018.1792
   PubMed Web of Science ®Google Scholar
• Sountoulides, P., & Moutzouris, G. (2014). Prostate-specific antigen screening, why have the guidelines changed? Expert Review of Anticancer Therapy, 14(11), 1277–1281. doi:10.1586/14737140.2014.971111
   PubMed Web of Science ®Google Scholar
• Souza, P. C., Textor, L. C., Melo, D. C., Nascimento, A. S., Skaf, M. S., & Polikarpov, I. (2017). An alternative conformation of ERβ bound to estradiol reveals H12 in a stable antagonist position. Scientific Reports, 7(1), 3509. doi:10.1038/s41598-017-03774-x
   PubMed Web of Science ®Google Scholar
• Tan, M. E., Li, J., Xu, H. E., Melcher, K., & Yong, E. L. (2015). Androgen receptor: Structure, role in prostate cancer and drug discovery. Acta Pharmacologica Sinica, 36(1), 3–23. doi:10.1038/aps.2014.18
   PubMed Web of Science ®Google Scholar
• Taplin, M.-E., Rajeshkumar, B., Halabi, S., Werner, C. P., Woda, B. A., Picus, J., … Small, E. J. (2003). Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. Journal of Clinical Oncology, 21(14), 2673–2678. doi:10.1200/JCO.2003.11.102
   PubMed Web of Science ®Google Scholar
• Thach, T. T., Lee, C. K., Woo Park, H., Lee, S. J., & Lee, S. J. (2016). Syringaresinol induces mitochondrial biogenesis through activation of PPARβ pathway in skeletal muscle cells. Bioorganic & Medicinal Chemistry Letters, 26(16), 3978–3983. doi:10.1016/j.bmcl.2016.07.001
   PubMed Web of Science ®Google Scholar
• Thelen, P., Wuttke, W., & Seidlová-Wuttke, D. (2014). Phytoestrogens selective for the estrogen receptor beta exert anti-androgenic effects in castration resistant prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology, 139, 290–293. doi:10.1016/j.jsbmb.2013.06.009
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. doi:10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Wang, H., Li, J., Gao, Y., Xu, Y., Pan, Y., Tsuji, I., … Li, X.-M. (2010). Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor. Asian Journal of Andrology, 12(4), 535–547. doi:10.1038/aja.2010.14
   PubMed Web of Science ®Google Scholar
• Wang, X., Li, X., Shi, W., Wei, S., Giesy, J. P., Yu, H., & Wang, Y. (2013). Docking and CoMSIA studies on steroids and non-steroidal chemicals as androgen receptor ligands. Ecotoxicology and Environmental Safety, 89, 143–149. doi:10.1016/j.ecoenv.2012.11.020
   PubMed Web of Science ®Google Scholar
• Wang, Z., Sun, H., Yao, X., Li, D., Xu, L., Li, Y., … Hou, T. (2016). Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes: The prediction accuracy of sampling power and scoring power. Physical Chemistry Chemical Physics, 18(18), 12964–12975.
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2014). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 47(1), 5.6.1–6. doi:10.1002/0471250953.bi0506s47
   Google Scholar
• Wu, J., Liu, S., Shen, X-y., Yang, N-y., Liu, Y., Tsuji, I., … Li, X-M. (2013). Phytoestrogens inhibiting androgen receptor signal and prostate cancer cell proliferation. Chemical Research in Chinese Universities, 29(5), 911–916. doi:10.1007/s40242-013-3123-6
   Web of Science ®Google Scholar
• Wu, W-F., Maneix, L., Insunza, J., Nalvarte, I., Antonson, P., Kere, J., … Gustafsson, J.-Å. (2017). Estrogen receptor β, a regulator of androgen receptor signaling in the mouse ventral prostate. Proceedings of the National Academy of Sciences of the United States of America, 114(19), E3816–E3822. doi:10.1073/pnas.1702211114
   PubMed Web of Science ®Google Scholar
• Zhang, Q., Feng, H., Qluwakemi, B., Wang, J., Yao, S., Cheng, G., … Yuan, M. (2017). Phytoestrogens and risk of prostate cancer: An updated meta-analysis of epidemiologic studies. International Journal of Food Sciences and Nutrition, 68(1), 28–42. doi:10.1080/09637486.2016.1216525
   PubMed Web of Science ®Google Scholar